These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23684217)

  • 1. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients.
    Xiong G; Chen X; Li X; Fang D; Zhang L; Yang L; Zhang L; Yao L; He Z; Zhou L
    J Formos Med Assoc; 2014 Aug; 113(8):521-6. PubMed ID: 23684217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and oncologic impact of chronic kidney disease for upper tract urothelial carcinoma in endemic area.
    Lee IW; Wang HJ; Liu HY; Chang YL; Wu YT; Chen YT; Cheng YT; Kang CH; Chuang YC; Luo HL
    J Formos Med Assoc; 2024 Jul; 123(7):758-763. PubMed ID: 38044211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma.
    Singla N; Gayed BA; Bagrodia A; Krabbe LM; Palazzi KL; Mirheydar H; Harrow B; Jacobs C; Youssef R; Darwish O; Sagalowsky A; Lotan Y; Derweesh I; Margulis V
    Urol Oncol; 2015 Jun; 33(6):268.e1-7. PubMed ID: 25862284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
    Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
    BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population.
    Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y
    Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
    Chen CY; Liao YM; Tsai WM; Kuo HC
    J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
    Raman JD; Lin YK; Kaag M; Atkinson T; Crispen P; Wille M; Smith N; Hockenberry M; Guzzo T; Peyronnet B; Bensalah K; Simhan J; Kutikov A; Cha E; Herman M; Scherr D; Shariat SF; Boorjian SA
    Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study.
    Cao Y; Gong M; Han Y; Xie J; Li X; Zhang L; Li Y; Song X; Zhu T; Li T
    Nephrology (Carlton); 2013 Apr; 18(4):307-12. PubMed ID: 23311442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience.
    Fang D; Xiong GY; Li XS; Chen XP; Zhang L; Yao L; He ZS; Zhou LQ
    J Formos Med Assoc; 2014 Nov; 113(11):820-7. PubMed ID: 24360737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.
    Chen XP; Xiong GY; Li XS; Matin SF; Garcia M; Fang D; Wang TY; Yu W; Gong K; Song Y; He ZS; He Q; Zhou LQ
    BJU Int; 2013 Nov; 112(7):917-24. PubMed ID: 23905945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
    Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
    BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
    Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
    Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy.
    Lee KH; Chen YT; Chung HJ; Liu JS; Hsu CC; Tarng DC
    Ren Fail; 2016; 38(1):77-83. PubMed ID: 26513686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of postoperative estimated glomerular filtration rate between kidney donors and radical nephrectomy patients, and risk factors for postoperative chronic kidney disease.
    Lee SH; Kim DS; Cho S; Kim SJ; Kang SH; Park J; Park SY; Chang SG; Jeon SH
    Int J Urol; 2015 Jul; 22(7):674-8. PubMed ID: 26012527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
    Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    Grasso M; Fishman AI; Cohen J; Alexander B
    BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.